Score de confiance 8/100
Dr Alardati Hosam
👤 2 ans d'expérience
8,176+
Patients seen
2
Years in practice
8
Publications
2
Languages spoken
À propos
Dr Hosam Alardati is a dedicated Pathologist currently practising at a prominent specialist medical facility and research centre in Riyadh, Saudi Arabia. He is highly regarded for his meticulous approach to diagnostic medicine and his commitment to advancing patient care through precise pathological evaluations. Dr Alardati provides reassuring and expert diagnostic support, ensuring that patients and their treating physicians receive accurate information to guide effective treatment plans.
Throughout his career, Dr Alardati has developed a strong clinical focus on oncological pathology. He specialises in the diagnosis and study of complex malignancies, including chromophobe renal cell carcinoma, clear cell renal cell carcinoma, and colorectal cancer. Furthermore, his expertise extends to the evaluation of breast cancer, particularly concerning genetic mutations, as well as rare conditions such as medulloblastoma and primary thyroid haemangioma. His comprehensive understanding of these complex diseases allows for highly tailored patient management.
In addition to his clinical responsibilities, Dr Alardati is deeply involved in medical research, contributing significantly to the fields of pathology and oncology. He has co-authored numerous peer-reviewed studies focusing on tumour pathophysiology, genetic markers in cancer, and rare diagnostic cases. By remaining at the forefront of scientific advancements, he ensures that his diagnostic practices are informed by the latest evidence, ultimately enhancing the quality of care provided to his patients.
Throughout his career, Dr Alardati has developed a strong clinical focus on oncological pathology. He specialises in the diagnosis and study of complex malignancies, including chromophobe renal cell carcinoma, clear cell renal cell carcinoma, and colorectal cancer. Furthermore, his expertise extends to the evaluation of breast cancer, particularly concerning genetic mutations, as well as rare conditions such as medulloblastoma and primary thyroid haemangioma. His comprehensive understanding of these complex diseases allows for highly tailored patient management.
In addition to his clinical responsibilities, Dr Alardati is deeply involved in medical research, contributing significantly to the fields of pathology and oncology. He has co-authored numerous peer-reviewed studies focusing on tumour pathophysiology, genetic markers in cancer, and rare diagnostic cases. By remaining at the forefront of scientific advancements, he ensures that his diagnostic practices are informed by the latest evidence, ultimately enhancing the quality of care provided to his patients.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Alardati Hosam
Formation et études
-
2017–2023 MD · Medicine and Surgery
-
2023–2027 Residency · Clinical Pathology
-
2027–2028 Fellowship · Subspecialty training
Carrière et postes
-
2027-09–2028-08 Junior consultant
Licences et assurance
Licences médicales
SA — Organización Médica Colegial de España (OMC)
Certifications du conseil
European Board of Clinical Pathology
Assurance responsabilité professionnelle :
Generali Healthcare · 1,000,000 EUR couverture · No claims on file
Procédures réalisées
| Procédure | Code | Total à vie |
|---|---|---|
| GP consultation | 99213 | 2,202 |
| Annual physical exam | 99395 | 2,380 |
| Vaccination administration | 90471 | 1,740 |
| Minor procedure (skin) | 17110 | 171 |
Services et tarifs
| Service | Durée | Modalité | Prix |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 180.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 450.00 EUR |
Cabinet, équipe & en pratique
Vidéos
Recherche et publications
indice h : 5 · i10 : 14
-
European registry analysis of Clinical Pathology outcomes
DOI: 10.5453/euroclin.2025.0 · PMID: 38275613 · cité par 130
-
Outcomes of Clinical Pathology in adults — a multi-centre cohort
DOI: 10.9346/euroclin.2024.1 · PMID: 34146700 · cité par 88
-
European registry analysis of Clinical Pathology outcomes
DOI: 10.8817/euroclin.2023.2 · PMID: 33493499 · cité par 70
-
Outcomes of Clinical Pathology in adults — a multi-centre cohort
DOI: 10.5336/euroclin.2022.3 · PMID: 34444854 · cité par 20
Conférences invitées
- Practical updates in Clinical Pathology European Annual Congress (Clinical Pathology) · Vienna · 2024 · invited
- Single-centre experience in Clinical Pathology National Society Meeting · Riyadh · 2023 · oral abstract
Récompenses et adhésions
Récompenses
- 🏆 Top-rated Clinical Pathology — Riyadh · EuroClinics Patient Choice · 2025 · regional
Adhésions à des sociétés
- WONCA Europe — Family Doctors — Member · Depuis 2028
- national college of family doctors — Member · Depuis 2028
- European Union of Medical Specialists (UEMS) — Member · Depuis 2028
Articles de ce médecin
- Patient education Patient guide to Clinical Pathology
- Awareness When should you see a clinical pathology?
Pour les patients internationaux
- Coordinateur
- Patient liaison · alardati.hosam@euroclinics.example
Emplacement
1 baliseAvis des patients
Partagez votre expérience — aidez d'autres patients à trouver le bon médecin. Rédiger un avis →
Avis récents
-
★★★★★ ✓ Vérifié Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Vérifié Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Vérifié Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.